Sprintec and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Sprintec (ethinyl estradiol; norgestimate), especially for people who are female, 20-29 old, have been taking the drug for 2 - 5 years also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Weight decreased when taking Sprintec. It is created by eHealthMe based on reports of 3,556 people who have side effects when taking Sprintec from the FDA, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Weight decreased?

Weight decreased is found to be associated with 3,415 drugs and 4,717 conditions by eHealthMe. Check the latest studies of Weight decreased.

On May, 04, 2026

3,556 people reported to have side effects when taking Sprintec.
Among them, 47 people (1.32%) have Weight decreased.

Among these 47 people:

How long have people been on Sprintec when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Sprintec? *

female: 100 %
male: 0.0 %

What is the age of people who have Weight decreased when taking Sprintec? *

What are other drugs people take besides Sprintec? *

What are other side effects people have besides Weight decreased? *

Nausea (feeling of having an urge to vomit): 12 people, 25.53%
Stress And Anxiety: 10 people, 21.28%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 19.15%
Hair Loss: 8 people, 17.02%
Abnormal Dreams: 7 people, 14.89%
Drowsiness: 5 people, 10.64%
Fatigue (feeling of tiredness): 5 people, 10.64%
Nausea And Vomiting: 5 people, 10.64%
Dizziness: 5 people, 10.64%
Cough: 5 people, 10.64%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 36.17%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 29.79%
Drowsiness: 9 people, 19.15%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 12.77%
Premenstrual Syndrome: 2 people, 4.26%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 4.26%
Depression: 2 people, 4.26%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.13%
Amino Acid Metabolism Disorder: 1 person, 2.13%
Asthma: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprintec:

Sprintec (4,397 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

How severe was Weight decreased and when was it recovered:

Weight decreased in Sprintec

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestimate:

Weight decreased and drugs with ingredients of ethinyl estradiol; norgestimate (213 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,415 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,717 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Sprintec) and Sprintec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.